COL11A1 Gene Marshall Syndrome Genetic Test
At DNA Labs UAE, we offer the COL11A1 Gene Marshall Syndrome Genetic Test at a cost of AED 4400.0.
Test Components:
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery:
Results will be delivered within 3 to 4 weeks.
Method:
The test is conducted using NGS (Next-Generation Sequencing) technology.
Test Type:
This test focuses on Ear Nose Throat Disorders and is recommended for patients referred by an ENT Doctor.
Test Department:
The test is conducted by our Genetics department.
Pre Test Information:
Prior to the test, it is important to provide the clinical history of the patient who is going for the PTPN23 Gene Ciliogenesis related disorder NGS Genetic DNA Test. A Genetic Counselling session will be conducted to draw a pedigree chart of family members affected with the PTPN23 Gene Ciliogenesis related disorder NGS Genetic DNA Test gene PTPN36.
Test Details:
The COL11A1 gene is associated with Marshall syndrome, also known as type II Stickler syndrome. Marshall syndrome is a rare genetic disorder characterized by abnormalities in the connective tissues, affecting various parts of the body including the eyes, ears, and skeleton.
NGS genetic testing is a technique used to analyze multiple genes simultaneously and detect mutations or variations in the DNA sequence. In the context of Marshall syndrome, NGS genetic testing can identify mutations or variations in the COL11A1 gene that may be responsible for the development of the disorder.
By analyzing the entire coding region of the COL11A1 gene, NGS testing provides a comprehensive assessment of genetic changes associated with Marshall syndrome. This information can confirm a diagnosis, predict the risk of developing the condition, and inform treatment decisions.
It is important to note that genetic testing for Marshall syndrome should be performed by a qualified healthcare professional or genetic counselor who can interpret the results and provide appropriate counseling and guidance.
| Test Name | COL11A1 Gene Marshall syndrome Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Ear Nose Throat Disorders |
| Doctor | ENT Doctor |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for PTPN23 Gene Ciliogenesis related disorder NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PTPN23 Gene Ciliogenesis related disorder NGS Genetic DNA Test gene PTPN36 |
| Test Details | COL11A1 gene is associated with Marshall syndrome, also known as type II Stickler syndrome. Marshall syndrome is a rare genetic disorder characterized by abnormalities in the connective tissues, which can affect various parts of the body including the eyes, ears, and skeleton. NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously and detect mutations or variations in the DNA sequence. In the context of Marshall syndrome, NGS genetic testing can be used to identify mutations or variations in the COL11A1 gene that may be responsible for the development of the disorder. By analyzing the entire coding region of the COL11A1 gene, NGS testing can provide a comprehensive assessment of genetic changes that may be associated with Marshall syndrome. This can help in confirming a diagnosis, predicting the risk of developing the condition, and informing treatment decisions. It is important to note that genetic testing for Marshall syndrome should be performed by a qualified healthcare professional or genetic counselor who can interpret the results and provide appropriate counseling and guidance. |
